HOHumeyra Hilal Ozturk

Humeyra Hilal Ozturk

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Humeyra Hilal Ozturk has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Investigating the Role of Oxidative Stress Parameters in the Spectrum of Preschool Anxiety Disorders

    by Elifnur Cuhacioglu, Özlem Dogan, Humeyra Hilal Ozturk, Merve Cikili‐Uytun

    Aim: This study sought to clarify the contribution of oxidative stress to anxiety disorders in preschool‐aged children by examining whether serum levels of Nrf2, Keap1, Sestrin‐2, Superoxide Dismutase, and GABPa play etiological roles. Method: The sample included 65 children aged 3–6 years, comprising 22 children diagnosed with anxiety disorders, 22 with subclinical anxiety, and 21 healthy controls. Anxiety disorders were evaluated using a preschool‐age psychiatric assessment. Parents completed the Preschool Anxiety Scale, the Short Temperament Scale for Children, and the CBCL 1.5–5 years forms. Venous blood samples were collected from all participants. Serum levels of Nrf2, Keap1, Sestrin‐2, superoxide dismutase, and GABPa were then measured. Results: Nrf2 levels differed significantly among all three groups ( p < 0.05), whereas GABPa levels differed significantly only between the anxiety and control groups ( p < 0.05). Positive correlations were observed between levels of Nrf2 and GABPa and both the duration and severity of anxiety disorders. Receiver operating characteristic analyses indicated that Nrf2 levels had significant predictive value for the diagnosis of anxiety disorders ( p < 0.001), whereas GABPa levels did not reach statistical significance ( p = 0.06). Conclusions: The results identify potential biological markers associated with anxiety disorders in preschool‐aged children and suggest that Nrf2 may represent a potential candidate biomarker, pending confirmation in larger, longitudinal studies.

  • Increased Serum Netrin-1 Levels Among Children Diagnosed With ADHD

    by Hümeyra Hilal Öztürk, Selen Sezen, Elçin Çağlar, Serenay Elgün Ülkar, Sadettin Burak Açıkel

    Objective: ADHD is a common neurodevelopmental disorder of childhood characterized by altered projections of dopaminergic neurons and connectivity issues in various brain regions. In our study, we aim to investigate the potential effects of axon guidance molecules, Netrin-1 and Semaphorins 3A, 4D, and 7A, on these connectivity problems by examining the levels of these molecules in the peripheral blood of children with ADHD compared to healthy controls. Methods: A total of 43 children with ADHD and 40 healthy controls 6 to 12 years of age were included in the study. The K-SADS-PL was administered to exclude any additional psychopathologies (excluding ODD in the ADHD group). The Revised Child Anxiety and Depression Scale was provided to the children, while parents completed the revised Conners’ Parent Rating Scale (CPRS-R), the Social Responsiveness Scale (SRS), and the Behavior Rating Inventory for Executive Functioning (BRIEF). Additionally, teachers of the ADHD group were given the Conners’ Teacher Rating Scale. Furthermore, the WISC-4 was administered to assess the IQ profile of 35 children in the ADHD group. Results: Netrin-1 was found to be statistically higher in the ADHD group. When the R-CADS scores were recalculated taking the covariate into account, the significant increase in the ADHD group remained. There was no statistically significant difference between the two groups for semaphorin 3A, 4D, and 7A. The positive correlation of Netrin-1 with the hyperactivity subscores on the CPRS-R and the Global Executive Score on the BRIEF scale is noteworthy. Conclusion: Netrin-1 may play a role in the etiopathogenesis of ADHD. Further studies are needed to clarify the relationship between Netrin-1 and ADHD.

  • Neuroinflammatory Pathways in Autism Spectrum Disorder: Unraveling the Role of Sirtuin 1 in Clinical Samples

    by Merve Cikili‐Uytun, Esra Yurumez, Banu Kaymak, Ozlem Dogan, Humeyra Hilal Ozturk, Beyza Nur Baysar Kanoglu, Didem Behice Oztop

    Despite extensive research, the etiological factors contributing to autism spectrum disorder (ASD) remain incompletely understood, with potential influences ranging from genetic predispositions to environmental factors. Sirtuin 1 (SIRT1), an NAD + ‐dependent histone deacetylase involved in mitigating oxidative stress and its association with other neurodevelopmental disorders, explores its function in ASD. This study aimed to elucidate the relationship between SIRT1 and inflammatory cytokines, specifically interleukin 6 (IL‐6) and tumor necrosis factor alpha (TNF‐α), in patients with ASD. This study enrolled 46 children diagnosed with ASD and 44 typically developing (TD) children aged 36–120 months. Diagnosis of ASD was confirmed using DSM‐5 criteria through clinical and observational assessments conducted by three experienced child and adolescent psychiatrists at the outpatient Infant Mental Health unit of Ankara University. The Childhood Autism Rating Scale (CARS) and the Repetitive Behavior Scale‐Revised (RBS‐R) were used to assess autistic behaviors. Analysis of serum levels of SIRT1, IL‐6, and TNF‐α revealed no significant differences between the ASD group and the TD group. Correlation analysis demonstrated a significant positive relationship between SIRT1 levels and IL‐6 ( r = 0.71, p < 0.001) and TNF‐α ( r = 0.86, p < 0.001). Additionally, regression phenomena exhibited a moderate negative correlation with IL‐6 ( r = −0.32, p = 0.02) and TNF‐α ( r = −0.38, p = 0.008). Age was positively correlated with levels of IL‐6, TNF‐α, and SIRT1. However, no correlations were found between these parameters and gender. These findings do not support the hypothesized role of disturbances in the expression of circulating cytokines and SIRT1 as indicators of systemic inflammation in autism. Further longitudinal studies should examine these immune markers in blood samples from large sample sizes.


  • Neurodegeneration in Autism: A Study of Clusterin, Very Long-Chain Fatty Acids, and Carnitine

    by Esra Yurumez, Merve Cikili-Uytun, Banu Kaymak, Ozlem Dogan, Humeyra Hilal Ozturk, Beyza Nur Baysar-Kanoglu, Didem Behice Oztop

    The clinical identification of regression phenomena in ASD lacks specific biological or laboratory criteria and is often based on family history and highly subjective observations by clinicians. The present study aimed to investigate the potential role of plasma clusterin (CLU), very long-chain fatty acids (VLCFA), and carnitine as biomarkers of neurodegeneration in children with autism spectrum disorder (ASD) with and without regression. By exploring these biomarkers, we sought to provide insights into mitochondrial dysfunction, glial activation, and lipid metabolism, which may contribute to the pathophysiology of ASD and aid in the early diagnosis and intervention of regression phenomena in ASD. Ninety children aged 2–6 years were included: 30 with autism spectrum disorder (ASD), 30 with regressive ASD, and 30 healthy controls. Psychiatric assessments were conducted using DSM-5 criteria, CARS, ABC, RBS-R, and ASSQ scales. Regression in ASD was evaluated retrospectively using a modified ADI-R questionnaire. Fasting blood samples were collected, and plasma clusterin (CLU), VLCFA, and carnitine levels were measured. Statistical analyses were performed using MANOVA to assess the effect of group differences on dependent biochemical variables. Serum clusterin and carnitine levels showed no significant differences between groups. However, C22 VLCFA levels were significantly higher in both autism groups compared to controls (p = 0.04), with post hoc analysis indicating the difference between the non-regressive and control groups (p = 0.02). Serum carnitine was positively correlated with stereotypic behaviors subscale scores (r = 0.37, p = 0.004) and total scores (r = 0.35, p = 0.006) of RBS-R. Our study provides insights into the complexities of biomarker research in autism spectrum disorder (ASD), highlighting the challenges in identifying consistent biological markers for regression and non-regression phenotypes. Although no significant findings were observed, further biomarker studies are essential to distinguish possible endophenotypes, improve early diagnosis, and uncover potential therapeutic targets in ASD.